EOS Imaging has raised US$51 million in its IPO on NYSE Euronext
Venture-backed medical device company EOS Imaging has raised US$51 million in its IPO on NYSE Euronext. Based on the opening trade price, the company is valued at approximately US$146 million. Investors include medical device-focused venture capital firm NBGI Ventures and Edmond de Rothschild Investment Partners, which has been the lead investor and the company’s largest shareholder since 2005.
EOS Imaging designs, develops and markets EOS, a medical imaging system revolutionizing the treatment chain of the main osteoarticular diseases (hips, knees, back) and related orthopedic surgery. Based on the work of Physics Nobel Prize Winner Georges Charpak, the EOS system is the first imaging solution capable of producing, in one step, a 2D and 3D image of the upright skeleton with a very low radiation dose. EOS 2D/3D images are produced in the patient’s natural functional position, raising the accuracy of diagnosis, surgery and osteoarticular pathological follow-up.
The success of the IPO confirms EOS Imaging’s outstanding technology pedigree, its sound commercial and clinical proposition and its potential for strong commercial growth on a global level.
Oaklins’ team in France was appointed by the shareholders of EOS Imaging to launch an initial public offering and proposed listing of the company’s shares on compartment C of the regulated market of NYSE Euronext.
![](/files/styles/hero_image/public/HEALTHCARE%20deal%203_0.jpg)
![](/api/deal-party-images/35401/deal-parties.png)
Talk to the deal team
Related deals
Winking Studios Limited completes a secondary fundraising of US$20 million
Winking Studios has successfully raised US$20 million to fund its business strategy and future plans, such as strategic acquisitions, alliances and joint ventures as well as secondary or dual listings, to grow the group’s market share and broaden its customer base globally.
Learn moreFRP Advisory Group plc has finalized a successful secondary placing
FRP Advisory Group plc has completed a fundraising. The book was oversubscribed and approximately £20.4 million (US$33 million) of shares were sold by certain directors and partners of FRP to new and existing institutional investors at 128 pence per ordinary share.
Learn moreLeika Medical Equipments Ltd. has been acquired by Angus Capital
The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.
Learn more